Amneal Pharmaceuticals, Inc. 13D

Tushar Patel now beneficially owns 17.6% of Amneal Pharmaceuticals via 61.3 million shares following additional shares received in the Kashiv BioSciences acquisition, with no stated activist intentions.

Tushar Patel, through entities TI SIE 2 and Rock Nola, LLC, reports beneficial ownership of 61,341,678 shares of Amneal Pharmaceuticals, Inc. Class A Common Stock, representing 17.6% of the outstanding class, following the issuance of 12,763,469 new shares to Rock Nola as part of Amneal’s $375 million cash-and-stock acquisition of Kashiv BioSciences; this Amendment No. 6 updates the economic stake resulting from the Kashiv Acquisition and does not outline any activist intentions, governance changes, or other strategic plans under Item 4.

Filing Facts

CIK

1723128

Ticker

AMRX

Form

13D

Source Type

fda

Accession

0000898432-26-000654

Alert Tier

7